title: Stratified medicine: drugs meet genetics.
abstract: It is well recognised that genetic factors play a major role in the development of respiratory diseases such as asthma and chronic obstructive pulmonary disease. However, whilst extensive data exist on diseases caused primarily by single gene defects, such as α1-antitrypsin deficiency, the genetic factors responsible for the development of complex disease are only now being defined. Once the gene(s) responsible for the heritable element of disease risk are known, the next step is to identify the mechanisms underlying the pathophysiological effects of the causal mutations in these genes. This process can be time consuming, but allows a full understanding of the mechanisms underlying disease development to be obtained. This knowledge can then potentially be used to stratify patient groups within (or even across) disease boundaries and then to target therapy more effectively.
authors: Division of Therapeutics and Molecular Medicine, Queen's Medical Centre, Nottingham, UK. Ian.Hall@nottingham.ac.uk
authors: Ian P
authors: IP
authors: Hall
mesh_terms: D000818:Animals; D001249:Asthma / Q000188:drug therapy / Q000235:genetics; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000235:genetics; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D008171:Lung Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D058990:Molecular Targeted Therapy; D018579:Patient Selection; D010641:Phenotype; D057285:Precision Medicine; D011237:Predictive Value of Tests; D011379:Prognosis; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy / Q000235:genetics; D019141:Respiratory System Agents / Q000627:therapeutic use*; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D019141:Respiratory System Agents